
Yatin Suneja
Stock Analyst at Guggenheim
(4.87)
# 301
Out of 5,144 analysts
463
Total ratings
48.3%
Success rate
21.2%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics | Reiterated: Buy | $14 → $8 | $0.3345 | +2,291.63% | 6 | Nov 18, 2026 | |
| LYCA Lycia Therapeutics | Initiated Coverage: Buy | $75 | $30.92 | +142.56% | 1 | Nov 17, 2026 | |
| YARW Yarrow Bioscience | Reiterated: Buy | $60 | $14.21 | +322.24% | 2 | Nov 15, 2026 | |
| ALMS Alumis | Reiterated: Hold | n/a | $4.84 | - | 8 | Nov 13, 2026 | |
| EYPT EyePoint | Reiterated: Hold | n/a | $0.2959 | - | 11 | Nov 13, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $800 → $1,050 | $305.06 | +244.19% | 18 | Nov 13, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $46 → $48 | $38.71 | +24.00% | 12 | Nov 13, 2026 | |
| SRZN Surrozen | Reiterated: Buy | $45 → $80 | $29.98 | +166.84% | 4 | Nov 11, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $20 → $8 | $1.04 | +672.95% | 11 | Nov 10, 2026 | |
| IMUX Immunic | Reiterated: Buy | $70 | $7.33 | +854.98% | 3 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $28.04 | +256.63% | 12 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $55 | $2.78 | +1,878.42% | 8 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $9.78 | +257.87% | 6 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $32.50 | +115.38% | 2 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $13.76 | +263.37% | 2 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 → $250 | $135.95 | +83.89% | 27 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $40 | $7.51 | +432.62% | 4 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $135 | $93.81 | +43.91% | 8 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $110 | $43.57 | +152.47% | 3 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $300 | $250.79 | +19.62% | 29 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,030 → $1,100 | $957.76 | +14.85% | 34 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $46 | $9.99 | +360.46% | 8 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.50 | +300.00% | 18 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $27.75 | +98.20% | 5 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.13 | - | 4 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,185 → $1,120 | $947.52 | +18.20% | 27 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $82.10 | +113.15% | 11 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.07 | - | 10 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.02 | +1,468.63% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $96.32 | +107.64% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $38.78 | +132.08% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $86.98 | +129.94% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $222 | $165.92 | +33.80% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $62 | $33.21 | +86.69% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.95 | +408.47% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.15 | +1,117.39% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $26.41 | +127.19% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $45.61 | +206.95% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.25 | +77.78% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.99 | n/a | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $18.32 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.63 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.01 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $20.83 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.08 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $29.89 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $0.7948 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $13.04 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $62.71 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.92 | n/a | 1 | Aug 13, 2014 |
Neumora Therapeutics
Nov 18, 2026
Reiterated: Buy
Price Target: $14 → $8
Current: $0.3345
Upside: +2,291.63%
Lycia Therapeutics
Nov 17, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $30.92
Upside: +142.56%
Yarrow Bioscience
Nov 15, 2026
Reiterated: Buy
Price Target: $60
Current: $14.21
Upside: +322.24%
Alumis
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.84
Upside: -
EyePoint
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2959
Upside: -
Praxis Precision Medicines
Nov 13, 2026
Reiterated: Buy
Price Target: $800 → $1,050
Current: $305.06
Upside: +244.19%
Roivant Sciences
Nov 13, 2026
Reiterated: Buy
Price Target: $46 → $48
Current: $38.71
Upside: +24.00%
Surrozen
Nov 11, 2026
Reiterated: Buy
Price Target: $45 → $80
Current: $29.98
Upside: +166.84%
Zura Bio
Nov 10, 2026
Reiterated: Buy
Price Target: $20 → $8
Current: $1.04
Upside: +672.95%
Immunic
Nov 9, 2026
Reiterated: Buy
Price Target: $70
Current: $7.33
Upside: +854.98%
Nov 6, 2026
Reiterated: Buy
Price Target: $100
Current: $28.04
Upside: +256.63%
Nov 5, 2026
Reiterated: Buy
Price Target: $100 → $55
Current: $2.78
Upside: +1,878.42%
Nov 5, 2026
Reiterated: Buy
Price Target: $35
Current: $9.78
Upside: +257.87%
Nov 5, 2026
Reiterated: Buy
Price Target: $70
Current: $32.50
Upside: +115.38%
Nov 5, 2026
Reiterated: Buy
Price Target: $50
Current: $13.76
Upside: +263.37%
Nov 3, 2026
Reiterated: Buy
Price Target: $275 → $250
Current: $135.95
Upside: +83.89%
Nov 3, 2026
Reiterated: Buy
Price Target: $45 → $40
Current: $7.51
Upside: +432.62%
Nov 3, 2026
Reiterated: Buy
Price Target: $130 → $135
Current: $93.81
Upside: +43.91%
Nov 3, 2026
Reiterated: Buy
Price Target: $100 → $110
Current: $43.57
Upside: +152.47%
Nov 2, 2026
Reiterated: Buy
Price Target: $280 → $300
Current: $250.79
Upside: +19.62%
Nov 2, 2026
Reiterated: Buy
Price Target: $1,030 → $1,100
Current: $957.76
Upside: +14.85%
Oct 29, 2026
Reiterated: Buy
Price Target: $51 → $46
Current: $9.99
Upside: +360.46%
Oct 29, 2026
Reiterated: Buy
Price Target: $22
Current: $5.50
Upside: +300.00%
Oct 28, 2026
Reiterated: Buy
Price Target: $55
Current: $27.75
Upside: +98.20%
Oct 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.13
Upside: -
Oct 22, 2026
Reiterated: Buy
Price Target: $1,185 → $1,120
Current: $947.52
Upside: +18.20%
Oct 20, 2026
Reiterated: Buy
Price Target: $175
Current: $82.10
Upside: +113.15%
Sep 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.07
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $1.02
Upside: +1,468.63%
Aug 10, 2026
Reiterated: Buy
Price Target: $200
Current: $96.32
Upside: +107.64%
Aug 6, 2026
Reiterated: Buy
Price Target: $90
Current: $38.78
Upside: +132.08%
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $86.98
Upside: +129.94%
Jul 31, 2026
Reiterated: Buy
Price Target: $200 → $222
Current: $165.92
Upside: +33.80%
May 26, 2026
Reiterated: Buy
Price Target: $44 → $62
Current: $33.21
Upside: +86.69%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $2.95
Upside: +408.47%
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.15
Upside: +1,117.39%
May 7, 2026
Reiterated: Buy
Price Target: $60
Current: $26.41
Upside: +127.19%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $45.61
Upside: +206.95%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $11.25
Upside: +77.78%
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $2.99
Upside: n/a
Feb 27, 2025
Reiterated: Hold
Price Target: $20
Current: $18.32
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $8.63
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.01
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $20.83
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.08
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $29.89
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $0.7948
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $13.04
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $62.71
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $13.92
Upside: n/a